Cannabis is perceived to be more ‘advantageous’ than conventional sleep aids, with many consumers ditching them altogether, a new study has found.
Most people who reported using cannabis to get a good night’s rest in a recent study have quit using over the counter or prescription sleep aids.
More than 80% of the 1,255 cannabis users surveyed for the Washington State University-led analysis reported no longer using over the counter or prescription sleep aids such as melatonin and benzodiazepines.
Instead, they had a strong preference for inhaling high-THC cannabis by smoking or vaporising flower, two fast-acting methods that previous research has shown can help with difficulty falling asleep.
Interestingly, around half of the people in the study also specifically reported using cannabis strains containing CBD and the terpene myrcene, an aromatic plant compound found in hops, basil and other plants in addition to cannabis.
“One of the findings that surprised me was the fact that people are seeking the terpene myrcene in cannabis to assist with sleep,” said Carrie Cuttler, senior author of the study and associate professor of psychology at WSU.
“There is some evidence in the scientific literature to support that myrcene may help to promote sleep, so cannabis users seemed to have figured that out on their own.”
Cannabis compared to conventional sleep aids
For the study published in the journal Exploration of Medicine, Cuttler and psychology doctoral student Amanda Stueber analysed self-report data from individuals on their use of cannabis and other sleep aids or no sleep aids, and what effects they perceived the different products to have.
Data for the study were provided by Strainprint®, a Canada-based medical technology company.
Participants reported varying morning outcomes and side effects.
Cannabis users more commonly reported feeling refreshed, focused and better able to function in the morning after using cannabis, along with experiencing fewer headaches and less nausea compared to when they were using traditional sleep aids.
However, cannabis users also reported feeling sleepier, as well as more anxious and irritable in the morning. They were also more likely to report experiencing dry mouth and red eyes after using cannabis.
“In general, the use of cannabis for sleep-related issues was perceived as more advantageous than over the counter medications or prescription sleep aids,” Cuttler said.
“Unlike long-acting sedatives and alcohol, cannabis was not associated with a ‘hangover’ effect, although individuals reported some lingering effects such as sleepiness and changes in mood.”
The researchers also found that more than 60% of the study participants reported getting the recommended six to eight hours of sleep when using cannabis alone. Less than 20% of the sample reported getting six to eight hours of sleep while using a prescription or over-the-counter sleep aid – or cannabis combined with a sleep aid.
Only 33.8% of participants reported using cannabis edibles to help them sleep, and 14.1% opted for capsules containing THC.
These alternatives are known for their longer-lasting effects but were less commonly chosen, possibly due to the need for quicker relief when falling asleep.
Recommendations for future research
While most of the findings came out in favour of cannabis use for sleep, the study has its limitations.
There was a strong selection bias for people who were already using cannabis because they perceive it to be beneficial, Cuttler cautioned.
“Not everyone is going to find that cannabis helps with their sleep and future research needs to employ more objective sleep measures to provide a more comprehensive understanding of the effects of cannabis for sleep,” she said.
Cuttler and Stueber hope that the study will provide some valuable insights for healthcare professionals who work with cannabis users and individuals seeking alternative solutions for sleep-related problems.
The research also supports the use of future clinical trials to validate the efficacy of myrcene and other isolated compounds in cannabis for sleep that don’t have the intoxicating effects of THC.
- Research shows ‘remarkable’ effects of cannabis in treatment of skin cancer
- Optimism despite delays: Ireland’s journey toward cannabis decriminalisation
- Medical Cannabis in the Management of Glaucoma
- President Zelensky signs bill legalising medical cannabis in Ukraine
- EU signals increasing shift in attitude towards cannabis reform
- Jersey passes ‘de jure’ decriminalisation of cannabis for personal use
News4 months ago
FSA drops recommended daily dose of CBD to 10mg – everything you need to know
Pain5 months ago
Medical cannabis ‘effective’ and ‘fast-acting’ for neuropathic pain – study
News4 months ago
UK government accepts ACMD recommendations for CBD products
Industry4 months ago
First UK-grown cannabis medicine expected by end of 2023
News5 months ago
The Netherlands to launch cannabis legalisation pilot December 2023
News5 months ago
BBC documentary highlights ‘pot luck’ of access to cannabis on NHS
Science5 months ago
New cannabis research: cancer, Type 2 diabetes, autism, fibromyalgia and skin disorders
News4 months ago
Europe’s first legal cannabis dispensaries to open under sixth Swiss pilot